Streetbeat News

NUVO

Holdco Nuvo Group D.G Ltd.

Industry

Surgical and Medical Instrument Manufacturing

Open

0.22

Mkt cap

5.7M

Volume

559K

High

0.22

P/E Ratio

-0.17

52-wk high

21.50

Low

0.17

Div yield

N/A

52-wk low

0.17

The U.S. Bankruptcy Court for the District of Delaware has imposed significant trading restrictions on equity interests in Holdco Nuvo Group D.G Ltd. and its affiliates, following a court ruling.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:40 am

In Monday's after-market session, several health care stocks experienced significant price movements. Conduit Pharmaceuticals, TNF Pharmaceuticals, and Holdco Nuvo Group DG were among the top gainers, while Renalytix, Bluejay Diagnostics, and IO Biotech saw notable declines.

Portfolio Pulse from Benzinga Insights

September 02, 2024 | 8:31 pm

Several healthcare stocks experienced significant price movements during Monday's intraday session. Notable gainers included Theriva Biologics, WORK Medical Technology, and Cingulate, while Catheter Precision and NuCana were among the biggest losers.

Portfolio Pulse from Benzinga Insights

September 02, 2024 | 4:30 pm

Trading for a certain asset was halted and then resumed at 3:15 PM ET. The article provides details on the halt status and resumption times.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:15 pm

Holdco Nuvo Group D.G Ltd. and its subsidiaries have filed for Chapter 11 bankruptcy in Delaware. They plan to continue operations as debtors in possession during the bankruptcy process.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 5:27 pm

Trading for an unspecified asset was halted at 1:02:03 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 5:02 pm

Nuvo Group has withdrawn its request for the acceleration of the effective date of its registration statement until further notice.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 7:20 pm

The article highlights significant pre-market movements in health care stocks on Monday. Notable gainers include Scinai Immunotherapeutics (NASDAQ:SCNI), ENDRA Life Sciences (NASDAQ:NDRA), Venus Concept (NASDAQ:VERO), Tharimmune (NASDAQ:THAR), TRACON Pharma (NASDAQ:TCON), and Kineta (NASDAQ:KA). On the losing side, Ovid Therapeutics (NASDAQ:OVID), Bluejay Diagnostics (NASDAQ:BJDX), Elutia (NASDAQ:ELUT), Aptevo Therapeutics (NASDAQ:APVO), BIMI Holdings (NASDAQ:BIMI), and Holdco Nuvo Group DG (NASDAQ:NUVO) saw declines.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:07 pm

The article highlights the pre-market movements of 12 health care stocks on Thursday. Significant gainers include Longeveron (LGVN), JanOne (JAN), Bionomics (BNOX), BioRestorative Therapies (BRTX), Holdco Nuvo Group DG (NUVO), and Vivani Medical (VANI). Notable losers are Assure Holdings (IONM), Cara Therapeutics (CARA), Apyx Medical (APYX), Petros Pharma (PTPI), Catheter Precision (VTAK), and Connect Biopharma Holdings (CNTB).

Portfolio Pulse from Benzinga Insights

June 13, 2024 | 12:07 pm

The article highlights the performance of 12 health care stocks during Wednesday's after-market session. Notable gainers include Holdco Nuvo Group DG (NASDAQ:NUVO) with a 21.5% increase and Entero Therapeutics (NASDAQ:ENTO) with an 8.69% rise. Significant losers include Assure Holdings (NASDAQ:IONM) which fell by 38.4% and RenovoRx (NASDAQ:RNXT) which declined by 10.26%.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 8:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.